ClinicalTrialsFinder

Cancer of the Thyroid Clinical Trials in St Louis, Missouri

1 recruitingSt Louis, Missouri

Showing 1–1 of 1 trials

Recruiting
Phase 2

Lenvatinib 24 mg/Day Versus 10 mg/Day to Treat Symptomatic or Progressive Radioactive Iodine Resistant (RAIR) Differentiated Thyroid Cancer (DTC)

Thyroid CancerCancer of the Thyroid
Washington University School of Medicine34 enrolled1 locationNCT07092514